CAS 100021-05-4

Formel: C21H28O2

InChl: InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,5,16-19,23H,3,6-13H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1

InChI Key: LYRBZVWRTAFWPO-XUDSTZEESA-N

SMILES: CC[C@]12CC[C@@H]3[C@H]4CCC(=O)CC4=CC[C@H]3[C@@H]1CC[C@]2(C#C)O

Levonorgestrel EP Impurity P

CAS: 100021-05-4

Formel: C₂₁H₂₈O₂

Farbe und Form: White To Off-White Solid

Molekulargewicht: 312.45

Ref: 4Z-L-2210

5(6)-Dehydro-4(5)-dihydro D-(-)-Norgestrel (>90%)

Kontrolliertes Produkt

CAS: 100021-05-4

Impurity Levonorgestrel EP Impurity P
Applications 5(6)-Dehydro-4(5)-dihydro D-(-)-Norgestrel (Levonorgestrel EP Impurity P) is a Norgestrel (N689500) impurity.

Formel: C₂₁H₂₈O₂

Reinheit: >90%

Farbe und Form: Neat

Molekulargewicht: 312.45

Ref: TR-D229935

(17a)-13-Ethyl-17-hydroxy-18,19-dinorpregn-5-en-20-yn-3-one

Kontrolliertes Produkt

CAS: 100021-05-4

(17a)-13-Ethyl-17-hydroxy-18,19-dinorpregn-5-en-20-yn-3-one is a progestin that acts as an inhibitor of the P450 enzyme. It has been used in the treatment of women with fertility problems. (17a)-13-Ethyl-17-hydroxy-18,19-dinorpregn-5-en--20--yn--3--one has shown inhibitory effects on voltage dependent calcium channels and thus may have contraceptive properties. It has also been shown to be effective in the long term treatment of intrauterine devices. Low bioavailability is a disadvantage of this drug.br>br>

Formel: C₂₁H₂₈O₂

Reinheit: Min. 95%

Farbe und Form: Powder

Molekulargewicht: 312.45 g/mol

Ref: 3D-FE20961

Levonorgestrel EP Impurity P

CAS: 100021-05-4

Formel: C₂₁H₂₈O₂

Molekulargewicht: 312.45

Ref: ST-EA-CP-L19016